CID 83977

N-(4-bromobenzenesulfonyl)erythromycylamine

Structural Information

Molecular Formula
C43H73BrN2O14S
SMILES
CCC1C(C(C(C(C(CC(C(C(C(C(C(=O)O1)C)OC2CC(C(C(O2)C)O)(C)OC)C)OC3C(C(CC(O3)C)N(C)C)O)(C)O)C)NS(=O)(=O)C4=CC=C(C=C4)Br)C)O)(C)O
InChI
InChI=1S/C43H73BrN2O14S/c1-14-31-43(10,52)36(48)24(4)33(45-61(53,54)29-17-15-28(44)16-18-29)22(2)20-41(8,51)38(60-40-34(47)30(46(11)12)19-23(3)56-40)25(5)35(26(6)39(50)58-31)59-32-21-42(9,55-13)37(49)27(7)57-32/h15-18,22-27,30-38,40,45,47-49,51-52H,14,19-21H2,1-13H3
InChIKey
YLHRPRHVBKHNDZ-UHFFFAOYSA-N
Compound name
4-bromo-N-[10-[4-(dimethylamino)-3-hydroxy-6-methyloxan-2-yl]oxy-2-ethyl-3,4,9-trihydroxy-12-(5-hydroxy-4-methoxy-4,6-dimethyloxan-2-yl)oxy-3,5,7,9,11,13-hexamethyl-14-oxo-oxacyclotetradec-6-yl]benzenesulfonamide
Related CIDs

2D Structure

compound 2d structure
1
Annotation Hits

0
References

3
Patents

952.3966 Da
Monoisotopic Mass

5.8
XlogP (predicted)

Profile

Predicted Collision Cross Section

Adduct m/z Predicted CCS (Ų)
[M+H]+ 953.40388 288.2
[M+Na]+ 975.38582 295.1
[M-H]- 951.38932 287.4
[M+NH4]+ 970.43042 290.1
[M+K]+ 991.35976 276.1
[M+H-H2O]+ 935.39386 274.2
[M+HCOO]- 997.39480 290.9
[M+CH3COO]- 1011.4105 293.5
[M+Na-2H]- 973.37127 317.4
[M]+ 952.39605 301.6
[M]- 952.39715 301.6
m/z: mass to charge ratio of the adduct.
Predicted Collision Cross Section (CCS) values (Ų) per adduct calculated using CCSbase.

Literature stripe

No literature data available for this compound.

Patent stripe

patents stripe